Dianthus Therapeutics

White arrow on a road pointing to the rising sun
Biotech

Dianthus' gMG asset blooms as phase 2 win sets up pivotal plans

Dianthus Therapeutics is advancing its challenge for the gMG market, outlining plans to move into phase 3 on the back of hits in a midphase study.
Nick Paul Taylor Sep 8, 2025 9:24am
photo of a life preserver in open water

Magenta hoists Dianthus onto its shoulders via reverse merger

May 3, 2023 10:02am